Page last updated: 2024-09-04

atrasentan and Acute Disease

atrasentan has been researched along with Acute Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boemke, W; Francis, RC; Höhne, C; Kaczmarczyk, G1
Guimarães, CL; Rae, GA; Trentin, PG1
Ayach, B; Battistini, B; Blouin, A; Gosselin, M; Jeng, AY; Opgenorth, TJ; Tsang, J; Wang, FH; Wessale, J; Wu-Wong, JR1
Ayach, B; Battistini, B; Blouin, A; Cernacek, P; Jeng, AY; Opgenorth, T; Tsang, J; Verreault, M; Wessale, J1
Carano, RA; Fisher, M; Opgenorth, TJ; Sotak, CH; Takano, K; Tatlisumak, T1

Other Studies

5 other study(ies) available for atrasentan and Acute Disease

ArticleYear
Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonist.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Action Potentials; Acute Disease; Angiotensin II; Animals; Atrasentan; Blood Pressure; Cardiac Output; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Hemorrhage; Norepinephrine; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Vascular Resistance; Vasodilator Agents; Vasopressins

2002
Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in mice.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Acute Disease; Analysis of Variance; Animals; Atrasentan; Bosentan; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Evans Blue; Lung; Male; Mice; Mice, Inbred Strains; Neutrophil Infiltration; Oleic Acid; Pyrimidines; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Respiratory Distress Syndrome; Sulfonamides

2002
Effects of a selective endothelin A receptor antagonist, ABT-627, in healthy normotensive anaesthetized rats developing acute pulmonary air embolism.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Acute Disease; Animals; Atrasentan; Embolism, Air; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Gene Expression; Lung; Male; Models, Animal; Oxygen; Pulmonary Embolism; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin

2002
Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Acute Disease; Animals; Aspartic Acid Endopeptidases; Atrasentan; Benzofurans; Cardiovascular Agents; Disease Models, Animal; Embolism, Air; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-Converting Enzymes; Endothelins; Hemodynamics; Hypertension, Pulmonary; Male; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Time Factors; Ventricular Dysfunction, Right

2004
A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study.
    Stroke, 1998, Volume: 29, Issue:4

    Topics: Acute Disease; Administration, Oral; Animals; Arterial Occlusive Diseases; Atrasentan; Binding, Competitive; Biological Availability; Cerebral Arterial Diseases; Diffusion; Endothelin Receptor Antagonists; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Perfusion; Pyrrolidines; Rats; Rats, Sprague-Dawley

1998